The machine, which pumps blood to the heart and lungs to sustain life, is not typically used in early treatment. But providing early access to the therapy may be the difference between life and death for those who qualify, according to a Feb. 15 news release from Mayo Clinic.
Because it has to be done quickly, first responders must see if a candidate qualifies, and if they do and first responders are able to transport them to a hospital in less than 30 minutes, those patients will be able to receive access to extracorporeal membrane oxygenation treatment.
A study of the method of treatment, published in the Lancet, found that patient outcomes improved by about six times for those who received ECMO treatment.
“We are changing the way we deliver care to our out-of-hospital cardiac arrest patients. This is an innovative therapy that we are bringing to the people of Rochester and surrounding communities,” Alexander Finch, MD, a Mayo Clinic emergency medicine physician and lead for the initiative, said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
